Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes
about
AMPK: An emerging target for modification of injury-induced pain plasticity.Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexesMitochondrial hormesis and diabetic complicationsBnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signalingMitotoxicity in distal symmetrical sensory peripheral neuropathiesSchwann cell interactions with axons and microvessels in diabetic neuropathy.Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain.Endocrine Imbalance Associated With Proteome Changes in Diabetes.Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathyPGC-1α regulation of mitochondrial degeneration in experimental diabetic neuropathy.Long-chain acyl coenzyme A synthetase 1 overexpression in primary cultured Schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction.Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetesModulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathyModulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory NeuronsDiabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?Ciliary neurotrophic factor activates NF-κB to enhance mitochondrial bioenergetics and prevent neuropathy in sensory neurons of streptozotocin-induced diabetic rodents.Gentisic acid sodium salt, a phenolic compound, is superior to norepinephrine in reversing cardiovascular collapse, hepatic mitochondrial dysfunction and lactic acidemia in Pseudomonas aeruginosa septic shock in dogs.The use of metformin is associated with decreased lumbar radiculopathy pain.Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapy.VEGF-B promotes recovery of corneal innervations and trophic functions in diabetic mice.Repeated monitoring of corneal nerves by confocal microscopy as an index of peripheral neuropathy in type-1 diabetic rodents and the effects of topical insulinMechanisms of distal axonal degeneration in peripheral neuropathies.Dorsal Root Ganglia Mitochondrial Biochemical Changes in Non-diabetic and Streptozotocin-Induced Diabetic Mice Fed with a Standard or High-Fat DietMelatonin prevents mitochondrial dysfunction and promotes neuroprotection by inducing autophagy during oxaliplatin-evoked peripheral neuropathy.Mitochondrial dysfunction precedes depression of AMPK/AKT signaling in insulin resistance induced by high glucose in primary cortical neurons.Targeting the Diabetic Chaperome to Improve Peripheral Neuropathy.Therapeutic targeting of diabetic retinal neuropathy as a strategy in preventing diabetic retinopathy.Hydroxytyrosol improves mitochondrial function and reduces oxidative stress in the brain of db/db mice: role of AMP-activated protein kinase activation.Targeting AMPK for the Alleviation of Pathological Pain.Lipids: A Suitable Therapeutic Target in Diabetic Neuropathy?Diabetes impairs an interleukin-1β-dependent pathway that enhances neurite outgrowth through JAK/STAT3 modulation of mitochondrial bioenergetics in adult sensory neuronsThe potent, indirect adenosine monophosphate- activated protein kinase activator R419 attenuates mitogen-activated protein kinase signaling, inhibits nociceptor excitability, and reduces pain hypersensitivity in mice.Perspectives on Peripheral Neuropathy as a Consequence of Metformin-Induced Vitamin B12 Deficiency in T2DM.Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats.Axonal transport in a peripheral diabetic neuropathy model: sex-dimorphic features.Diabetes-induced abnormalities of mitochondrial function in rat brain cortex: the effect of n-3 fatty acid diet.A novel curcumin derivative for the treatment of diabetic neuropathy.Adenosine Monophosphate-Activated Protein Kinase Abates Hyperglycaemia-Induced Neuronal Injury in Experimental Models of Diabetic Neuropathy: Effects on Mitochondrial Biogenesis, Autophagy and Neuroinflammation.AMPK activation by peri-sciatic nerve administration of ozone attenuates CCI-induced neuropathic pain in rats.Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy.
P2860
Q27021903-104EFA23-3C4E-4C2F-995E-9989806EF4B3Q28115112-675A080D-34FA-42A8-AB89-C735911F2852Q28388387-E1D5FD17-8A27-4295-BD42-9F7A564AEB6BQ28580570-C1026210-F8B2-414D-8578-F0384F1AC2DAQ28834071-0626AE92-A2E6-4BC5-BECF-F4EFD1C33275Q30238727-A061BB87-369F-4510-BEAA-3A511BC623F0Q30383901-7FB94C0C-4E1C-4864-A94B-6D837274DFCFQ30401167-0EF86391-F361-456A-834B-BBA255BA73D6Q30836715-8AD425A2-6897-4A97-914C-D5348FB18721Q33623182-D54D77DC-87EC-4A00-9A95-1D21E85535C9Q33862382-CE1FB316-BBB4-4945-BE6F-04BFD0FA8FEBQ35213829-D38B177D-9DEF-48BE-9390-407303506D68Q35911991-9930718D-D2DA-4C9B-BC7D-CEA121965CE9Q36070681-4A18DDA7-6ED2-47AB-9473-AC8F47D6AEBBQ36293649-C4E01A47-4892-44DE-840C-6ECE951380B6Q36463405-3C81C009-1E37-43A0-950C-85E06AC219DAQ37124179-6FD6B248-A145-463D-B4F6-66EF564E75BDQ37391076-BE108CC0-65DD-4583-8E0F-A5BE4658AAC3Q37550709-82EB5550-53B6-4DF3-84CB-DA045DBF3CFDQ37587659-33E6DCC5-5FF4-4373-9CBE-0625BAAF5F37Q37695080-3AF0BCAD-BB77-431A-A63F-2B30F7851359Q38330759-A945D975-C1A7-483B-924D-80155D39D20FQ38641932-7A94FE68-DDA3-40C6-8AF5-AB93605D7ECFQ38719679-7EB62A92-2067-4E4A-A7A2-058D155B1166Q38790202-B7DDBA09-B243-4B8D-A434-829C547FF9E0Q38869328-8AA2AC5C-6EB1-45E6-91F9-10097A857B82Q38873909-C56C7AE7-D991-497A-BE00-AD8CB113F8E3Q38885757-F0FD7B4D-C475-4AEE-901C-DD6964BC01E9Q38998418-2BFD3B88-A29A-4976-95F7-63E04F4B017EQ39132982-AEC1201E-F374-4DE3-98F5-C7096B18B6B2Q39439940-6056D9B0-AFF4-4735-90E6-5F1A6B6EADA3Q41169804-EA8B0F20-CAC9-41C7-A022-AF8BC0B4EF4CQ41448734-DB24E791-B33D-408F-95B2-2D2283ADB9A7Q46019226-6D02C64D-E5CC-440B-B704-63D9DB94C2FDQ47551144-B5B179CA-F5FF-4122-AB47-C248C235FFC6Q47885935-C41BDBE7-8C1B-4768-A4FF-B05630B3AFB0Q50085300-C767D164-621B-4F2C-AA07-40440A5E0322Q50871143-EF6C7014-DB14-44CB-9521-AA2D554644EBQ51390386-BE9EB318-90CB-4D5C-B00B-AE7957D0F640Q51582079-7356FBC6-9C6F-45E3-B071-1AD0419BC39E
P2860
Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@ast
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@en
type
label
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@ast
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@en
prefLabel
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@ast
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@en
P2093
P2860
P356
P1433
P1476
Impaired adenosine monophospha ...... ipheral neuropathy in diabetes
@en
P2093
Alexandra Marquez
Darrell R Smith
Dwane Morrow
Jason Schapansky
Nigel A Calcutt
Paul Fernyhough
Subir K Roy Chowdhury
Suzanne Gomes
P2860
P304
P356
10.1093/BRAIN/AWS097
P407
P577
2012-05-04T00:00:00Z